Myomo to Report First Quarter 2025 Financial Results on May 7
The Company will host a conference call the same day at 4:30 p.m. ET with prepared remarks by Paul R. Gudonis, chairman and chief executive officer, and David Henry, chief financial officer.
Participants are encouraged to pre-register for the conference call using this . Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may dial in by calling, 844-707-6932 (
A replay of the webcast will be available beginning approximately one hour after the completion of the live conference call at . A dial-in replay of the call will be available until May 21, 2025; please dial 877-344-7529 (
About Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the
View source version on businesswire.com:
Myomo:
[email protected]
Alliance Advisors IR:
Tirth T. Patel
[email protected]
212-201-6614
Source: Myomo, Inc.